NCT01702181: A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis |
|
|
| Completed | 1 | 92 | US | OPA-15406, Tacrolimus, Protopic, Placebo | Otsuka Pharmaceutical Development & Commercialization, Inc. | Atopic Dermatitis | 12/13 | 12/13 | | |
NCT02334787: A Phase 1 Trial of OPA-15406 Ointment in Healthy Adult Male Subjects |
|
|
| Completed | 1 | 32 | Japan | 0.3% OPA-15406 Ointment, OPA-15406 Ointment, 1% OPA-15406 Ointment, 3% OPA-15406 Ointment, Placebo Ointment | Otsuka Pharmaceutical Co., Ltd. | Atopic Dermatitis | 02/15 | 02/15 | | |
